Tuesday, July 5, 2016

BRIEF-Five Prime Therapeutics receives FDA orphan drug designation for FPA144 for treatment of gastric cancer

* Five prime therapeutics receives fda orphan drug

designation for fpa144 for the treatment of gastric cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)